Correlation Between Cardio Diagnostics and Enanta Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Enanta Pharmaceuticals.
Diversification Opportunities for Cardio Diagnostics and Enanta Pharmaceuticals
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cardio and Enanta is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Enanta Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Enanta Pharmaceuticals
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 4.16 times more return on investment than Enanta Pharmaceuticals. However, Cardio Diagnostics is 4.16 times more volatile than Enanta Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about -0.42 per unit of risk. If you would invest 28.00 in Cardio Diagnostics Holdings on September 5, 2024 and sell it today you would earn a total of 2.00 from holding Cardio Diagnostics Holdings or generate 7.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Enanta Pharmaceuticals
Performance |
Timeline |
Cardio Diagnostics |
Enanta Pharmaceuticals |
Cardio Diagnostics and Enanta Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Enanta Pharmaceuticals
The main advantage of trading using opposite Cardio Diagnostics and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Enanta Pharmaceuticals vs. Candel Therapeutics | Enanta Pharmaceuticals vs. Cingulate Warrants | Enanta Pharmaceuticals vs. Unicycive Therapeutics | Enanta Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Commodity Directory Find actively traded commodities issued by global exchanges |